Youthful Cancer Free Pill Poppers?

by ScienceDave | July 19, 2007 at 08:31 am
984 views | 4 Recommendations | 1 comment

Photos

Cell Cycle

Cell Cycle

see larger image

uploaded by ScienceDave

Could you imagine one day, popping back a few tiny white pills with your morning coffee, knowing you were both fighting time and cancer?  That's the hope for research published in the scientific journal Nature this week.  

Their conclusion - injecting a drug into mice that stimulates the production of the protein p53, one integral to regulating how cells divide, can help combat aging and cancer.  But how?

Well, first a little background on how cells divide.  Like most things in science, I learned about the cell cycle through an acronym - IPMAT stands for Interphase, Prophase, Metaphase, Anaphase, Telophase - the five stages of a cellular division.  The I in IPMAT concerns us here, as it involves the duplication of DNA and is also when p53 comes into action.  

During the transition between some of these stages, our cells have biochemical checkpoints.  These allow the cell to ensure everything is on the button before proceeding onwards.  If something has gone awry, and the cell cannot repair the damages incurred, then the countdown for self-destruction mode begins care of p53.

The protein p53 is integral in these checkpoints, and certain mutations in it can cause the cells to bypass all checkpoints like a diplomat at the airport.  Only these cells aren't interested in talking out a peaceful resolution but rather go on a replicating spree - cancer.

In recent years another role for p53 has been discovered.  It stimulates the cell to make antioxidants under stressful conditions.  These molecules are often described as mopping op 'free radicals' - the equivalent of an older brother telling your bully what's what, then taking away his fire crackers and stink bombs.

The above said, researchers wondered whether p53 might prevent both cancer and aging in mice....
As expected, mice with the extra copy of p53 had fewer tumours than regular mice, and their cells were less likely to turn cancerous when grown in a Petri dish. On average, the transgenic mice lived 16% longer than normal mice: 118 days versus 137. By comparison, mice on a calorie-restricted diet — another lifespan booster — get a 20% bump in life expectancy.

But the age boost wasn't just an effect of fewer mice dying of cancer. When the researchers looked only at cancer-free mice in the study, they found that these transgenic mice lived 25% longer, on average, than normal ones. The oldest mice in both groups died at about the same age, but more of the transgenic mice lived into their golden years than the normal ones.

When the researchers looked more closely at the youthful mice, they found higher levels of genes that combat oxidative damage than in regular rodents. The mice with extra p53 also held up better against a lethal dose of paraquat, a drug that causes oxidative damage.

So, 10-15 years from now if clinical trials actually begin, let alone finish, you might get to pop a few pills and know you're paying service to your cells.

Advertisement
recommend This comment thread is now closed
ryan
ryan
flagged this story as Good Stuff

at 09:44 on July 19th, 2007

nouseforadave, Good Stuff. Hope is perhaps the most powerful treatment in the meantime.

This story was created over 3 months ago, the comment thread is now closed.

NowPublic on Facebook

What is NowPublic?

NowPublic lets people work together to cover news events around the world.

Find out more

Crowd Power

ryan
First Flagged at 9:44 AM, Jul 19, 2007 by ryan
These members have powered this story:

Most Recommended Stories in Health

 

closeSign in to NowPublic

is reporting from